Peptide stacks, evidence checked.
Stacking is where peptide marketing is most confident and the evidence is thinnest. The finding repeats on almost every page below: the components have been studied alone, and the combination has never been tested against placebo or against either component by itself.
Two compounds acting on different mechanisms is a reason to hypothesise that combining them helps. It is not a measurement that combining them helps. Demonstrating synergy requires testing the combination against each component alone, and for the stacks below that study has essentially never been run.
The most popular healing combination in the field, named for a comic book character, and never once tested as a combination.
The Wolverine stack with a copper peptide added for skin, which introduces a problem the marketing rarely addresses.
Four compounds, one syringe, and zero studies of the combination.
The one popular stack whose mechanistic rationale is genuinely well founded, which makes the missing outcome evidence more conspicuous rather than less.
A real problem, a popular peptide answer, and an evidence base that points somewhere else entirely.
A pairing of two compounds with real clinical use in one country, minimal independent replication, and the most placebo-responsive endpoints in medicine.
The older version of the growth hormone pairing, with the same sound rationale and a less clean side-effect profile.
A category of blends built on a mistake about how cosmetic peptide evidence was generated.